Castle Biosciences Inc Cash Flow Reinvestment Rate
Castle Biosciences Inc cash flow reinvestment rate. Castle Biosciences Inc (CSTL) has a Cash Flow Reinvestment Rate of 1.05x as of June 2026, reinvesting $15.97 Million (capex $8.65 Million plus investments $-7.32 Million) from operating cash flow of $15.20 Million. Explore Castle Biosciences Inc debt service capacity to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Castle Biosciences Inc (2019–2025)
Cash flow reinvestment rate of Castle Biosciences Inc from 2019 to 2025. Historical reinvestment intensity for Castle Biosciences Inc across 4 annual periods. Explore reinvestment intensity of Castle Biosciences Inc to see what proportion of operating cash flow is directed to capital expenditures.
Castle Biosciences Inc Cash Flow Reinvestment Rate by Year (2019–2025)
Castle Biosciences Inc cash flow reinvestment rate by year from 2019 to 2025. Year-by-year capital reinvestment analysis for Castle Biosciences Inc. For the full cash flow conversion analysis, see CSTL cash generation efficiency.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.59x | $38.04 Million | $64.35 Million | $36.02 Million | ▼ -51.1% |
| 2024 | 1.21x | $78.46 Million | $64.87 Million | $28.33 Million | ▲ +25.6% |
| 2020 | 0.96x | $9.50 Million | $9.87 Million | $4.75 Million | ▲ +260.4% |
| 2019 | 0.27x | $1.87 Million | $7.01 Million | $937.00K | — |